Overview

Intravenous Iron in Adults With Cystic Fibrosis

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This pilot interventional cohort study will examine the effects of intravenous iron in adults with cystic fibrosis and iron deficiency.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oxford
Treatments:
Ferric Compounds